Results

Total Results: 1,147 records

Showing results for "event".

41. Final Evidence Summary: Hepatitis C Virus Infection in Adolescents and Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/hepatitis-c-screening
    March 02, 2020 - Pooled Adverse Event Rates for DAA Regimens. … DAA therapy was frequently associated with experiencing any adverse event (44 trials, n = 8045; 73.3% … harms were generally not well described (eTable 14 in the Supplement). 56-62 Rates of any adverse event … rates, DAA vs other antiviral treatment: Any adverse event (2 trials): RR, 0.65 (95% CI, 0.50-0.84 … (grade 3 joint injury) in 1 study The rate of any adverse event was 27% in 1 study and 71%-87% in

42. Archived: Coronary Heart Disease (Electrocardiography): Screening (2004) | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/coronary-heart-disease-electrocardiography-screening-2004
    February 03, 2004 - Calculators are available to ascertain a person's risk for having a CHD event; for example, a calculator … to estimate a person's risk for a CHD event in the next 10 years can be accessed at http://hp2010.nhlbihin.net … A negative test does not rule out the presence of severe CAS or a future CHD event. … low-risk asymptomatic populations, most positive ECG test results occur in those who will not have a CHD event … ETT can be normal or non-diagnostic in a large proportion of patients who will go on to have a CHD event

43. Screening for Coronary Heart Disease with Electrocardiography: USPSTF Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/cBv4SGePTvo7Er2HGFtbsN
    October 01, 2012 - many rest- ing and exercise ECG abnormalities are associated with an increased risk for a serious CHD event … Calculators are available to ascertain a person's 10-year risk for a CHD event. … Risk factors can be combined in many ways to allow classification of a person’s risk for a CHD event … The overall risk for a serious adverse event (one that requires hospitalization or causes sudden death … population-based registries that include symptomatic persons (10), the risk for any serious adverse event

44. Clinical Summary: Risk Assessment for Cardiovascular Disease With Nontraditional Risk Factors (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/uPbfDukSXmFDWq8FDwTgKj
    July 03, 2018 - Risk factors can be combined in many w ays to classify a person's risk for a CVD event.

45. Aspirin for the Prevention of Cardiovascular Disease: Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/Q4J7tsThw_6nwfB-p-f5Hp
    March 01, 2009 - that avoiding a myocardial infarction is of great value and that having a gastrointestinal bleeding event … 8.5 10.2 11.9 13.6 15.3 17 18.7 20.4 22.1 23.8 25.5 27.2 28.9 30.6 32.3 34 Type of event … The balance of benefits and harms varies by stroke risk and risk for a bleeding event. … After age 40 years, men have a 49% lifetime risk for a coronary heart disease event. … This is probably partly because of the older age in women at first event (7, 10).

46. Draft Research Plan: Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Interventions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/weight-loss-prevent-obesity-related-morbidity-mortality
    May 18, 2023 - Any adverse treatment-related harm after initiation of the intervention, including: Any adverse event … or serious adverse event Withdrawals or discontinuation of medication due to adverse effects Unhealthy

47. Draft Research Plan: Healthy Diet, Physical Activity, and/or Weight Loss to Prevent Cardiovascular Disease in Adults: Behavioral Counseling Interventions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/behavioral-counseling-interventions-promote-healthy-diet-physical-activity-weight-loss-prevent-cardiovascular-disease-adults
    May 18, 2023 - Any adverse treatment-related harm after initiation of the intervention, including: Any adverse event … or serious adverse event Withdrawals or discontinuation of medication due to adverse effects Unhealthy

48. Archived: Breast Cancer: Medications for Risk Reduction | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-medications-for-risk-reduction-2013
    September 15, 2013 - Comparison of fracture, cardiovascular event, and breast cancer rates at 3 years in postmenopausal women … (A severe event is regarded as equivalent to half a life-threatening event). … (A severe event is regarded as equivalent to half a life-threatening event). … (A severe event is regarded as equivalent to half a life-threatening event). … (A severe event is regarded as equivalent to half a life-threatening event).

49. Screening for Skin Cancer (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/XJDNVYtZUo-CJJcsWum98D
    October 12, 2012 - or individual characteristics that affect the likelihood of a specific therapy-associated adverse event

50. Zvvry6Wa4Sgj-Ejb3Brcvy (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/zVVRY6wa4Sgj-EJb3BRcVy
    November 01, 2013 - (A severe event is regarded as equivalent to half a life-threatening event.) … (A severe event is regarded as equivalent to half a life-threatening event.) … Comparison of fracture, cardiovascular event, and breast cancer rates at 3 years in postmenopausal women … (A severe event is regarded as equivalent to half a life-threatening event.) … (A severe event is regarded as equivalent to half a life-threatening event.)

51. Evidence Summary: Prevention of Human Immunodeficiency Virus (HIV) Infection: Preexposure Prophylaxis | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis
    June 11, 2019 - in 3 trials, 21 , 33 , 39 but only 1 reported results for event-driven (before and after sex) PrEP. … The estimate from 1 trial (n = 400) of event-driven PrEP (RR, 0.14 [95% CI, 0.03-0.63]) was similar to … . 67 One trial found event-driven PrEP in men who have sex with men associated with substantially reduced … b Assessed using medication event monitoring system. c Not estimable. … ) and whether adverse event temporary or permanent Moderate See Applicability column for KQ1, HIV

52. Archived: Evidence Summary: Prevention of Human Immunodeficiency Virus (HIV) Infection: Preexposure Prophylaxis | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis-june-2019
    June 11, 2019 - in 3 trials, 21 , 33 , 39 but only 1 reported results for event-driven (before and after sex) PrEP. … The estimate from 1 trial (n = 400) of event-driven PrEP (RR, 0.14 [95% CI, 0.03-0.63]) was similar to … . 67 One trial found event-driven PrEP in men who have sex with men associated with substantially reduced … b Assessed using medication event monitoring system. c Not estimable. … ) and whether adverse event temporary or permanent Moderate See Applicability column for KQ1, HIV

53. Archived: Menopausal Hormone Therapy: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/menopausal-hormone-therapy-preventive-medication-2012
    October 15, 2012 - disease or individual characteristics that affect the likelihood of a specific therapy-associated adverse event … individual characteristics that affect the likelihood of having a specific therapy-associated adverse event … (WHI) randomized, controlled trial show a trend toward an increased likelihood of having a cardiac event … Initiative was designed to evaluate the incidence of invasive breast cancer as the primary adverse event … Estimated Event Rate Differences Associated With the Use of Unopposed Oral Estrogen in Postmenopausal

54. Preexposure Prophylaxis for the Prevention of HIV Infection: Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/bQNXFv9Q5uaAQvWH6B7VWV
    June 11, 2019 - Eleven trials evaluated daily PrEP.12,14,17,18,21,27,31,39,40,42,43 Dosing was intermittent or event-driven … in 3 trials,21,33,39 but only 1 reported results for event-driven (before and after sex) PrEP.33 In … The estimate from 1 trial (n = 400) of event-driven PrEP (RR, 0.14 [95% CI, 0.03-0.63]) was similar to … a Study conducted in the United States, Canada, or Europe. b Assessed using medication event monitoring … risk of HIV infection vs no PrEP.33 No study evaluated the effectiveness of intermittent or event-

55. Screening for Asymptomatic Coronary Artery Disease: Systematic Evidence Review (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/-XKf9dRtb-S6oSsBzwsCdw
    December 08, 2003 - sensitivity is the proportion of all patients who go on to have a CHD event that had positive screening … 5 to 10 years, most positive test results will occur in patients who will not go on to have a CHD event … can be normal or nondiagnostic in an important proportion of patients who will go on to have a CHD event … electrocardiogram in apparently healthy men: a predictor of angina pectoris as an initial coronary event … ) 3.0� 2.0� (event) Age Knutsen et al., 198831� 7,682 45-68 68% Men of Asian descent

56. High-Priority Evidence Gaps For Clinical Preventive Services: 7th Annual Report to Congress (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annual-report-to-congress-2017%20(2).pdf
    January 01, 2017 - Identification of dyslipidemia and calculation of 10-year CVD event risk requires universal lipids … Thus, clinicians should discuss with patients the potential risk of having a CVD event and the expected … Thus, clinicians should discuss with patients the potential risk of having a CVD event and the expected … Thus, clinicians should discuss with patients the potential risk of having a CVD event and the expected … Thus, clinicians should discuss with patients the potential risk of having a CVD event and the expected

57. Clinical Summary: Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/kQWppPe7wLrdrHnbqM2BQu
    December 05, 2017 - individual characteristics that affect the likelihood of experiencing a specific therapy-associated adverse event

58. Aspirin for the Primary Prevention of Cardiovascular Events: A Summary of the Evidence (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/xUc_vXf7323faUQY7SePhT
    January 01, 2002 - Control Odds ratio Duration of Annual risk Approximate events/ events/ (95% CI) therapya for a CHD event … In this analysis, the estimated annual excess risk with aspirin was 0.1 event per 1,000 users. … Detection of events, definition of a “significant” bleeding event, and reporting of location of upper … Our estimates of expected event rates and these mean utility values can provide an initial framework … rate of 0.8% per year for CVD; this is equivalent to an event rate of 0.6% per year for CHD.

59. Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: Clinical Summary (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/h-FnuqpAKFeMyTDcr_m9tS
    April 05, 2016 - derived from the ACC/AHA pooled cohort equations to predict 10-y risk for first atherosclerotic CVD event

60. Menopausal Hormone Therapy for the Primary Prevention of Chronic Conditions: USPSTF Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/sTjqbTas6gW5pzaATpeBDn
    January 01, 2013 - or individual characteristics that affect the likelihood of a specific therapy-associated adverse event … - vidual characteristics that affect the likelihood of having a specific therapy-associated adverse event … (WHI) randomized, controlled trial show a trend toward an increased likelihood of having a cardiac event … Estimated Event Rate Differences Associated With the Use of Oral Estrogen and Progestin in Postmenopausal … Estimated Event Rate Differences Associated With the Use of Unopposed Oral Estrogen in Postmenopausal